The president’s tariffs on foreign drugs and furniture rely on national security laws outside the scope of current lawsuits.
Category: Drugs (Pharmaceuticals)
-
Trump’s Pharma Tariffs Spare Richest Drugmakers
Big companies like Novartis say new tariffs won’t hit them. “A win for Pharma,” Wall Street analysts said.
-
Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs
European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trump’s latest tariff barrage.
-
Trump Will Slap Tariffs on Imported Drugs, Trucks and Household Furnishings
The president said his tariffs would range from 25 to 100 percent and would go into effect next week.
-
The Company Behind Tylenol Tries to Navigate Its Latest Crisis
Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
-
Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growth
Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s growth are falling, too.
-
FDA OKs New Keytruda Shot for Cancer
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
-
F.D.A. Reviews Cases of Covid Vaccine Deaths
The agency plans to present accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.
-
California Passes Bill Allowing Omission of Patients’ Names From Abortion Pill Bottles
The intent is to protect health care providers who send the pills to patients in states with abortion bans, and to reassure patients who fear they could be identified.
-
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.
-
Trump Weighs Crackdown on Medicines From China
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
-
Health Care Costs for Workers Begin to Climb
A survey shows employers expect a sharp increase in benefit costs for next year, and many will want workers to shoulder more of the burden.